10x Genomics (TXG) Operating Income Growth (1y) (2019 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Operating Income Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 13.79% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 48.29% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 23.33% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 14.49% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | -1.59% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 411.30% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | -5.84% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 0.58% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -648.74% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | -164.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -164.91% |
| Mar 31, 2026 | 56.66% |
| Dec 31, 2025 | 60.79% |
| Sep 30, 2025 | 22.28% |
| Jun 30, 2025 | 172.18% |
| Mar 31, 2025 | 36.05% |
| Dec 31, 2024 | 9.69% |
| Sep 30, 2024 | 56.24% |
| Jun 30, 2024 | 34.13% |
| Mar 31, 2024 | -18.29% |
| Dec 31, 2023 | -138.95% |
| Sep 30, 2023 | -137.01% |
| Jun 30, 2023 | -0.38% |
| Mar 31, 2023 | -24.57% |
| Dec 31, 2022 | -45.90% |
| Sep 30, 2022 | -151.88% |
| Jun 30, 2022 | -511.13% |
| Mar 31, 2022 | -308.53% |
| Dec 31, 2021 | 96.14% |
| Sep 30, 2021 | 75.67% |